Proadrenomedullin levels and clinical features of SARS-CoV-2 coronavirus infection: a prospective clinical study
- 作者: Astapovsky A.A1, Drozdov V.N1, Shikh E.V1, Lazareva N.B1, Melkonyan G.G2, Meshcheryakov A.A2, Tsepkova E.V3
-
隶属关系:
- M. Sechenov First Moscow State Medical University (Sechenov University)
- Hospital for War Veterans № 3 of the Moscow Healthcare Department
- City Clinical Hospital № 40 of the Moscow Healthcare Department
- 期: 卷 29, 编号 5 (2022)
- 页面: 26-31
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/320996
- DOI: https://doi.org/10.18565/pharmateca.2022.5.26-31
- ID: 320996
如何引用文章
详细
全文:
作者简介
A. Astapovsky
M. Sechenov First Moscow State Medical University (Sechenov University)
Email: ai.astapovskii@gmail.com
Moscow, Russia
V. Drozdov
M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, Russia
E. Shikh
M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, Russia
N. Lazareva
M. Sechenov First Moscow State Medical University (Sechenov University)Moscow, Russia
G. Melkonyan
Hospital for War Veterans № 3 of the Moscow Healthcare DepartmentMoscow, Russia
A. Meshcheryakov
Hospital for War Veterans № 3 of the Moscow Healthcare DepartmentMoscow, Russia
E. Tsepkova
City Clinical Hospital № 40 of the Moscow Healthcare DepartmentMoscow, Russia
参考
- Zhu N., Zhang D., Wang W., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N EngiJ Med 2020;382(8):727-33. doi: 10.1056/nejmoa2001017.
- Poston J., Patel B., Davis A. Management of Critically III Adults With COVID-19. JAMA. 2020;323(18):1839-41. doi: 10.1001/jama.2020.4914.
- Varga Z., Flammer A., Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-18. Doi: 10.1016/ s0140-6736(20)30937-5.
- Wilson D., Schefold J., Baldir J., et al. Adrenomedullin in COVID-19 induced endotheliitis. Critical Care. 2020; 24(1):411. doi: 10.1186/s13054-020-03151-7.
- Imai Y, Kuba K., Rao S., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-16. doi: 10.1038/nature03712.
- Vieceli Dalla Sega F, Fortini F, Spadaro S., et al. Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study Clin Transplat Med. 2021;11(3):e283. Doi: 10.1002/ ctm2.283.
- Na gele M., Haubner B., Tanner F, et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atheroscler. 2020;314:58-62. Doi: 10.1016/j. atherQselerosis.o02Q.10.014.
- Qiu P, Zhou Y, Wang F, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020;32(9):1869-78. Doi: 10.1007/ s40520-020-01664-3.
- Wu Z, McGoogan J. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020;323(13):1239. Doi: 10.1001/ jrmr.2020.2648.
- Schdnauer R., Els-Heindl S., Bssk-Siskingsr A. Adrenomedullin - new perspectives of a potent peptide hormone. J Pept Sci. 4917;43(7-8):474-85. doi: 10.1002/psc2953.
- Nakamura M, Yoshida H., Makita S., et al. Potent and Long-Lasting Vasodilatory Effects of Adrsnomsdullin in Humans. Circulat. 1997;95(5):1214-21. doi: 10.1161/01.cir.95.5.1214.
- Voors A, Kremer D., Geven C., et al. Adrsnomsdullin in heart failure: pathophysiology and therapeutic application. Eur. J. Heart Failure. 4918;41(4):163-71. Doi: 10.1002.1366.
- Tsmms2fsld-Wollbrйsk B., Brell B., David I., et al. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock.Intens Care Med. 2007;33(4):703-10. Doi: 10.1007/ s00134-007-0561-y.
- Pereira J., Azevedo A., Bas'lio C., et al. Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia? Revista Portug Pneumol. (English Edition). ~016;(6):308-1. Doi: 10.1016/j. rppnen.2016.03.012.
- Spoto S., Fogolari M., De Florio L., et al. Prosaisitonin and MR-proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock. Microb Pathogen. 2019;137:103763. doi: 10.1016/j.misprtS.2019.103763.
- Hirayama N., Kitamura K., Imamura T, et al. Secretion and clearance of the mature form of adrenomedullin in humans. Life Sci. 1999;64(26):2505-509. doi: 10.1016/s0024-3205(99)00208-8.
- Morgena N., Struck J., Alonso C., Bergmann A. Measurement of Midregional Proadrenomedullin in Plasma with an Immunoluminomstris Assay. Clin. Chemistry. 2005;51(10):1823-29. Doi: 10.1373/ siinsSsm.2005.051110.
- Saeed K., Wilson D., Bloos F, et al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi-centre derivation and validation study. Critical Care. 2019;23(1):255. doi: 10.1186/s13054-019-2329-5.
- Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)», версия 11 от 07.05.2021) [Электронный ресурс]. [Interim guidelines «Prevention, diagnosis and treatment of a new coronavirus infection (COVID-19)», version 11 of 05/07/2021). (In Russ.)]. URL: http2://xn--80as2fpsbagmfbls0a.xn-p1ri/ri/dos/872/rttrsS/Bmr_COVID-19_compressed.pdf
- National Early Warning Score (NEWS): Standardising the assessment of acuteillness severity in the NHS. Report of a working party. Royal College of Physicians. London: RCP.
- Asksemrnn M., Vsrisdsn S., Kuehnel M., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogsnssis in Covid-19. N Engl J Med. 2020;383(2):120-28. Doi: 10.1056/ NEJMor2015432.
- Zhou Y, Yang Q., Chi J., et al.Comorbidities and the risk of severe or fatal outcomes associated with coron'irus disease 2019: A systematic review and meta-analysis.Int. J. Infect. Dis. Q0Q0;99:47-56. doi: 10.1016/j.ijid.2020.07.029.
- Bermejo-Martin J., Almansa R., Torres A., et al. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Card'oYasc Res. 2020;116(10):e132-33. doi: 10.1093/cvr/ svrr140.
- Evans P, Rainger G., Mason J., et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardbsc Res. 2020;116(14):2177-84. doi: 10.1093/svr/svaa230.
- Goshua G.,Pins A.,Msiziis S M.,etal. Endot SsiiopatSy in COVD-W-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. Q0Q0;7(8):s575-8Q. Doi: 10.1016/ s2352-3026(20)30216-7.
- Oner O., Deveci F, Telo S., MR-proADM and MR-proANP levels in patients with acute pulmonary embolism. J Med Biochem. Q0Q0;39(3):3Q8-335. doi: 10.2478/jomb-2019-0049.
- Hoeiushi Y, Wsttsrstsn N., Maisel A. Response by Horiuchi et al. to Letter Regarding Article, "Biamrrksrs Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction". Circulation. 2021;143(8):s252-s253. Doi: 10.1161/ .120.051634.
- Huang D., Angus D., Kellum J., et al. Midregional Proadrenomedullin as a Prognostic Tool in Community-Acquired Pneumonia. Chest. 2009;136(3):823-31. doi: 19.1378/sSest.98-1981.
- Bernal-Morell E., Garcfa-Villalba E., Vera M., et al. Usefulness of m'dregimpro-rdrsnomsduiiin as a marker of organ damage and predictor of mortality in patients with sepsis. J Infect. 2018;76(3):249-57. doi: 10.1016/j.jinf.2017.12.003.
- Valenzuela Sanchez F, Valenzuela Mendez B., Rodriguez Gutierrez J., et al. Initial levels of mr-prordrsnomsduiiin: a predictor of severity in patients with influenza a virus pneumonia.Intens. Care Med Experim. 2015;3(Suppl. 1). doi: 10.1186/2197-425x-3-s1-r832.
- Julian-JimSnez A., Garcia D.E., Gonzalez Del Castillo J., et al. Key issues in emergency department management of COVID-19: proposals for improving care for patients in Latin America. Emergences. 2021;33:42-58.
- Viaggi B., Poole D., Tujjar O., et al. Mid regional pro-rdrsnomsduiiin for the prediction of organ failure in infection. Results from a single centre study. PLOS ONE. 2018;13(8):e0201491. Doi: 10.1371/ journal.pone.o201491.